semaglutide for weight loss in non diabetics side effects Comparative safety and of and tirzepatide: Implications clinical decision-making obesity management Exploring Oral Semaglutide: Weight Loss

Morozov VG, Khavinson VKh

This is an evolving area, and expert groups recommend individual risk assessment rather than blanket fear

GLP-1 medications can also interact with other treatments, like blood pressure or diabetes medications, potentially leading to dangerous drops in blood sugar levels

Canadian Laboratory Storage Protocols To preserve peptide integrity and copper-binding efficiency, strict cold-chain storage is recommended

NICE recommends considering bariatric surgery for adults with a BMI of 40 kg/m or more, or between 35-40 kg/m with significant obesity-related conditions, with expedited consideration for those with recent-onset type 2 diabetes